While RCTs remain the cornerstone of regulatory and HTA decision-making, advances in computational science are creating entirely new forms of evidence. Dalia Dawoud discuses two of the most promising developments: in-silico data & MIDD. Learn more: hubs.ly/Q04CsXK00

Cytel will be at PHUSE EU Connect 2026 in Glasgow! 📍 Stop by Booth 8 to speak with the Cytel team. See our upcoming presentations and book a meeting with a member of our team at PHUSE EU here: hubs.ly/Q04Crs7v0 See you in Glasgow! 👋

Independent physician review is the cornerstone of endpoint adjudication, but much of an Endpoint Adjudication Committee's efficiency and effectiveness is determined long before before a physician ever opens a case. Learn more: hubs.ly/Q04C3D8l0

NICE has published its AI Delivery Plan. Dalia Dawoud and Manuel Cossio discuss what HTA, HEOR, and market access professionals need to know and how sponsors can prepare as NICE's vision moves from experimentation to implementation. hubs.ly/Q04BR1nc0

Join us at our SCOPE Europe Drinks Reception in Barcelona tomorrow evening! Meet the Cytel team and continue the conversations that matter most. Space is limited — please register early to secure your place. hubs.ly/Q04zSFkj0 We hope to see you there!

Independent physician review is the cornerstone of endpoint adjudication, but much of an Endpoint Adjudication Committee's efficiency and effectiveness is determined long before before a physician ever opens a case. Learn more: hubs.ly/Q04zz3yg0

Cytel will be at SCOPE Europe! Our team is ready to help you bring greater visibility and predictability to your next clinical trial through connected trial design and clinical data oversight. Book your meeting today: hubs.ly/Q04zl9FK0 We hope to see you there!

How do you build an FSP workforce that controls costs without compromising quality, capability, or delivery? Join our experts for a webinar that explores how smarter workforce models can strengthen delivery, optimize resources, and create lasting value: hubs.ly/Q04z8JVD0

Next week, the Cytel team will be in Denver at the 2026 CDISC US Interchange!   Stop by and say hello to our team at Booth 6.   See you in Denver! hubs.ly/Q04yHknc0

How do you build an FSP workforce that controls costs without compromising quality, capability, or delivery? Join our experts for a webinar that explores how smarter workforce models can strengthen delivery, optimize resources, and create lasting value: hubs.ly/Q04y0Ndq0

Cytel will be at SCOPE Europe! Our team is ready to help you bring greater visibility and predictability to your next clinical trial through connected trial design and clinical data oversight. Book your meeting today: hubs.ly/Q04yj8_m0 We hope to see you there!

Workforce planning is often approached through the immediate needs of a role. But this can overlook something more fundamental. We discuss the broader questions sponsors should be asking to build teams that can continue to deliver well into the future. hubs.ly/Q04ybTWd0

Parkinson’s disease is the second-most common neurodegenerative disease affecting over 11 million people globally. We discuss common endpoints used in clinical trials with an illustrative case study on how those endpoints may be analyzed. hubs.ly/Q04ybT_L0

NICE has published its AI Delivery Plan. Dalia Dawoud and Manuel Cossio discuss what HTA, HEOR, and market access professionals need to know and how sponsors can prepare as NICE's vision moves from experimentation to implementation. hubs.ly/Q04y5PyW0

In the fight against rare diseases, data is our most precious resource — and greatest challenge. We discuss how, through a case study on IOPD, propensity score methods can be used to estimate treatment effectiveness in this rare disease setting. hubs.ly/Q04y5P-K0

How do you build an FSP workforce that controls costs without compromising quality, capability, or delivery? Join our experts for a webinar that explores how smarter workforce models can strengthen delivery, optimize resources, and create lasting value: hubs.ly/Q04y0N220

On September 24, join Manuel Cossio and Nicolas Rouillé as they explore the applications delivering tangible impact across biometrics and R&D, from data management and document automation to statistical programming. Register today! hubs.ly/Q04vzQ900

For sponsors planning umbrella, basket, or platform trials, recent FDA guidance has shifted the conversation toward what is required to ensure they are sufficiently rigorous for regulatory decision-making. We share what sponsors need to consider: hubs.ly/Q04vtZ7B0

The first EU JCA reports are beginning to highlight what teams need to consider as they prepare for JCA and subsequent national market access. On September 17, join Cytel experts as they discuss practical insights from early JCA experience. Register now! hubs.ly/Q04vqhGV0

Cytel will be at the 2026 ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop event in Rockville, Maryland! 📍 Our experts will be at Table 5. Stop by and say hello! Book a meeting: hubs.ly/Q04vkFV_0 See you in Rockville!